Cargando…

Bepridil is potent against SARS-CoV-2 In Vitro

Mostrar otras versiones (1)

Guided by a computational docking analysis, about 30 FDA/EMA-approved small molecule medicines were characterized on their inhibition of the SARS-CoV-2 main protease (M(Pro)). Of these tested small molecule medicines, six displayed an IC(50) value in inhibiting M(Pro) below 100 μM. Three medicines p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vatansever, Erol C., Yang, Kai, Kratch, Kaci C., Drelich, Aleksandra, Cho, Chia-Chuan, Mellott, Drake M., Xu, Shiqing, Tseng, Chien-Te K., Liu, Wenshe Ray
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263498/ https://www.ncbi.nlm.nih.gov/pubmed/32511370 http://dx.doi.org/10.1101/2020.05.23.112235

Ejemplares similares

Bepridil is potent against SARS-CoV-2 in vitro
por: Vatansever, Erol C., et al.
Publicado: (2021)

Self-Masked Aldehyde Inhibitors of Human Cathepsin L Are Potent Anti-CoV-2 Agents
por: Zhu, Jiyun, et al.
Publicado: (2022)

An Enhanced Hybrid Screening Approach to Identify Potent Inhibitors for the SARS-CoV-2 Main Protease From the NCI Compound Library
por: Li, Shuhua G., et al.
Publicado: (2022)

Bepridil Might be Potent Against the Coronavirus Disease 2019–related Electrical Storm in Brugada Syndrome
por: Higaki, Akinori
Publicado: (2022)

Effects of bepridil on early cardiac development of zebrafish
por: Wei, Ya-Lan, et al.
Publicado: (2022)

Responsiveness to bepridil predicts atrial substrate in patients with persistent atrial fibrillation
por: Yakabe, Daisuke, et al.
Publicado: (2021)

Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection In Vitro
por: Curreli, Francesca, et al.
Publicado: (2020)

Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain Fc fusion protein in mice
por: Liu, Xianglei, et al.
Publicado: (2020)

Successful treatment of bepridil-induced intraoperative torsades de pointes by isoproterenol infusion
por: Shimano, Ken, et al.
Publicado: (2021)

Bepridil monotherapy failed to prevent coronary vasospasm in a Brugada syndrome patient
por: Kazatani, Takuro, et al.
Publicado: (2022)

Suppression of Metastatic Ovarian Cancer Cells by Bepridil, a Calcium Channel Blocker
por: Zhang, Songzi, et al.
Publicado: (2023)

A multi-pronged evaluation of aldehyde-based tripeptidyl main protease inhibitors as SARS-CoV-2 antivirals
por: Ma, Yuying, et al.
Publicado: (2022)

A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antivirals
por: Alugubelli, Yugendar R., et al.
Publicado: (2022)

3-Chlorodiphenylamine activates cardiac troponin by a mechanism distinct from bepridil or TFP
por: Tikunova, Svetlana B., et al.
Publicado: (2019)

Evaluation of SARS-CoV-2 Main Protease Inhibitors Using a Novel Cell-Based Assay
por: Cao, Wenyue, et al.
Publicado: (2022)

Bepridil, a class IV antiarrhythmic agent, can block the TREK-1 potassium channel
por: Wang, Ying, et al.
Publicado: (2021)

Effect of polypharmacy on plasma bepridil concentration in patients with heart failure: a multicenter retrospective study
por: Asai, Yuki, et al.
Publicado: (2023)

Repurposing Halicin as a potent covalent inhibitor for the SARS-CoV-2 main protease
por: Yang, Kai S., et al.
Publicado: (2022)

Potent neutralization of SARS-CoV-2 by human antibody heavy-chain variable domains isolated from a large library with a new stable scaffold
por: Sun, Zehua, et al.
Publicado: (2020)

Bepridil decreases Aβ and calcium levels in the thalamus after middle cerebral artery occlusion in rats
por: Sarajärvi, Timo, et al.
Publicado: (2012)

Bepridil exhibits anti‐leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia
por: Baldoni, Stefano, et al.
Publicado: (2018)

Non-Selective Calcium Channel Blocker Bepridil Decreases Secondary Pathology in Mice after Photothrombotic Cortical Lesion
por: Lipsanen, Anu, et al.
Publicado: (2013)

Discovery of Highly Potent Fusion Inhibitors with Potential Pan-Coronavirus Activity That Effectively Inhibit Major COVID-19 Variants of Concern (VOCs) in Pseudovirus-Based Assays
por: Curreli, Francesca, et al.
Publicado: (2021)

An amber-encoding helper phage for more efficient phage display of noncanonical amino acids
por: Hampton, Joshua Trae, et al.
Publicado: (2023)

Accurate Mass Identification of an Interfering Water Adduct and Strategies in Development and Validation of an LC-MS/MS Method for Quantification of MPI8, a Potent SARS-CoV-2 Main Protease Inhibitor, in Rat Plasma in Pharmacokinetic Studies
por: Wang, Yang, et al.
Publicado: (2022)

Circulating Reelin promotes inflammation and modulates disease activity in acute and long COVID-19 cases
por: Calvier, Laurent, et al.
Publicado: (2023)

Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV
por: Morse, Jared S., et al.
Publicado: (2020)

A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2
por: Tai, Wanbo, et al.
Publicado: (2020)

Analysis of Infected Host Gene Expression Reveals Repurposed Drug Candidates and Time-Dependent Host Response Dynamics for COVID-19
por: Xing, Jing, et al.
Publicado: (2020)

Deciphering COVID-19 host transcriptomic complexity and variations for therapeutic discovery against new variants
por: Xing, Jing, et al.
Publicado: (2022)

Site-Specific Conversion of Cysteine in a Protein to Dehydroalanine Using 2-Nitro-5-thiocyanatobenzoic Acid
por: Qiao, Yuchen, et al.
Publicado: (2021)

Abnormal Pap smear frequency and comparison of repeat cytological follow-up with colposcopy during patient management: the importance of pathologist’s guidance in the management
por: Arslan, Erol, et al.
Publicado: (2018)

Extract of Pogostemon cablin Possesses Potent Anticancer Activity against Colorectal Cancer Cells In Vitro and In Vivo
por: Chien, Ju-Huei, et al.
Publicado: (2020)

An amber obligate active site-directed ligand evolution technique for phage display
por: Tharp, Jeffery M., et al.
Publicado: (2020)

Chloroquine analogs as antimalarial candidates with potent in vitro and in vivo activity
por: Aguiar, Anna C.C., et al.
Publicado: (2018)

Dual thio-digalactoside-binding modes of human galectins as the structural basis for the design of potent and selective inhibitors
por: Hsieh, Tung-Ju, et al.
Publicado: (2016)

Tailoring the secretome composition of mesenchymal stem cells to augment specific functions of epidermal regeneration: an in vitro diabetic model
por: Hodge, Jacob G., et al.
Publicado: (2023)

A cysteine protease inhibitor blocks SARS-CoV-2 infection of human and monkey cells
por: Mellott, Drake M., et al.
Publicado: (2020)

Manuka Honey: A Potent Cariostatic Agent— An in vitro Study
por: Beena, Javaregowda P, et al.
Publicado: (2018)

Potent Antimalarial Activity of Acriflavine In Vitro and In Vivo
por: Dana, Srikanta, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ss157k6mdnrq31f79vaq676j5a